Current Affairs - National - Discussion
Discussion Forum : National - Latest Current Affairs (Q.No. 4539)
4539.
Which pharma company seeks permission from DGCI for 'phase 2&3' clinical trials of Oxford vaccine under brand name "Covishield" in India?
Answer: Option
Explanation:
The Serum Institute of India (SII), which has partnered with British-Swedish pharma company AstraZeneca for manufacturing the University of Oxford vaccine candidate for COVID-19, has sought permission from the Drugs Controller General of India (DCGI) for conducting "phase 2/3 human clinical trials" of the potential vaccine.
Discussion:
1 comments Page 1 of 1.
Subash Subash said:
3 years ago
Very useful for the knowledge.
Post your comments here:
Quick links
Quantitative Aptitude
Verbal (English)
Reasoning
Programming
Interview
Placement Papers